RxDoctor Payments Data

Anne Goldsberry, MD

Procedural Dermatology · Scottsdale, AZNPI 1457581019

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.8% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations.

$4,811in general payments, 2019–2025

Across 213 payments — averaging $22.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$936
  • Merz North America, Inc.$667
  • Novartis$499
  • Regeneron Healthcare Solutions, Inc.$377
  • Sun Pharmaceutical Industries Inc.$284
  • Johnson & Johnson$252
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$4,70498%
  • Education$1082%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few procedural dermatology providers in Arizonato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,141,749
Medicare patients
885
Services billed
4,449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin550$2,069
Ketoconazole36$639
Doxycycline Hyclate41$588
Clobetasol Propionate12$471
Triamcinolone Acetonide31$268
Azithromycin72$238
ValacyclovirValacyclovir Hcl27$231
Hydrocortisone20$116
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$100

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →